Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $60,806 | 11 | 99.9% |
| Food and Beverage | $53.54 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $60,806 | 11 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $53.54 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,419 | 6 | Janssen Research & Development, LLC ($21,419) |
| 2023 | $39,388 | 5 | Janssen Research & Development, LLC ($39,388) |
| 2019 | $53.54 | 1 | Neurocrine Biosciences, Inc. ($53.54) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,150.00 | General |
| 07/25/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $6,037.50 | General |
| 05/13/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,150.00 | General |
| 03/08/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $862.50 | General |
| 02/12/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $9,056.25 | General |
| 01/25/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $3,162.50 | General |
| 12/18/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $4,025.00 | General |
| 12/14/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $10,637.50 | General |
| 09/12/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $8,050.00 | General |
| 07/07/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $4,600.00 | General |
| 05/09/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $12,075.00 | General |
| 05/20/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $53.54 | General |
| Category: NEUROLOGY | ||||||
About Dr. Ella Daly, MD
Dr. Ella Daly, MD is a Psychiatry healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1225224926.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ella Daly, MD has received a total of $60,860 in payments from pharmaceutical and medical device companies, with $21,419 received in 2024. These payments were reported across 12 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($60,806).
Practice Information
- Specialty Psychiatry
- Location Dallas, TX
- Active Since 09/18/2007
- Last Updated 09/18/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1225224926
Products in Payments
- INGREZZA (Drug) $53.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Dallas
Dr. Darin Okuda, M.d, M.D
Psychiatry — Payments: $739,134
Augustus Rush, Md, MD
Psychiatry — Payments: $737,518
Dr. Mary Knesevich, M.d, M.D
Psychiatry — Payments: $634,383
Michael Downing, Md, MD
Psychiatry — Payments: $423,962
Dr. Stephen Vobach, M.d, M.D
Psychiatry — Payments: $314,024
Madhukar Trivedi, Md, MD
Psychiatry — Payments: $264,753